NEW YORK , Aug. 22, 2024 /PRNewswire/ -- The global cardiopulmonary stress testing systems market size is estimated to grow by USD 2.18 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of almost 6.78% during the forecast period. Increasing number of heart specialty centers is driving market growth, with a trend towards technological advances.
However, high cost of stress testing devices poses a challenge. Key market players include Baxter International Inc., Becton Dickinson and Co.
, Biosensors International Group Ltd., Cardinal Health Inc., COSMED Srl, Fukuda Denshi Co.
Ltd, General Electric Co., Halma Plc, InBody Co. Ltd.
, Koninklijke Philips N.V., MGC Diagnostics Corp.
, Nasiff Associates Inc., Neurosoft, Nihon Kohden Corp., Nonin Medical Inc.
, OSI Systems Inc., SCHILLER AG, Siemens Healthineers AG, SunTech Medical Inc., Thermo Fisher Scientific Inc.
, and Vyaire Medical Inc.. Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report Cardiopulmonary Stress Testing Systems Market Scope Report Coverage Details Base year 2023 Historic period 2018 - 2022 Forecast period 2024-2028 Growth momentum & CAGR Accelerate at a CAGR of 6.
78% Market growth 2024-2028 USD 2181.8 million Market structure Fragmented YoY growth 2022-2023 (%) 6.23 Regional analysis North America, Europe, Asia, and Rest of World (ROW) Performing market contribution Europe at 33% Key countries US, Germany, Franc.